Pompholyx: what's new?
Wollina U.
Expert Opin Investig Drugs. 2008 Jun;17(6):897-904. doi: 10.1517/13543784.17.6.897.
Pompholyx.
Summers A.
Emerg Nurse. 2007 Sep;15(5):18-9. doi: 10.7748/en2007.09.15.5.18.c4249.
Photoaggravated pompholyx.
Nalluri R, Rhodes LE.
Photodermatol Photoimmunol Photomed. 2016 May;32(3):168-70. doi: 10.1111/phpp.12237. Epub 2016 Mar 2.
Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy.
Gerstenblith MR, Antony AK, Junkins-Hopkins JM, Abuav R.
J Am Acad Dermatol. 2012 Feb;66(2):312-6. doi: 10.1016/j.jaad.2010.12.034. Epub 2011 May 20.
Pompholyx: a review of clinical features, differential diagnosis, and management.
Wollina U.
Am J Clin Dermatol. 2010;11(5):305-14. doi: 10.2165/11533250-000000000-00000.
Acute and recurrent vesicular hand dermatitis not pompholyx or dyshidrosis.
Storrs FJ.
Arch Dermatol. 2007 Dec;143(12):1578-80. doi: 10.1001/archderm.143.12.1578.
Familial pompholyx.
Curth HO.
Arch Dermatol. 1969 Oct;100(4):520. doi: 10.1001/archderm.100.4.520b.
Pompholyx as a side effect of intravenous immunoglobulin (IVIg).
Doyle C, Eustace K.
BMJ Case Rep. 2022 Mar 30;15(3):e248772. doi: 10.1136/bcr-2022-248772.
Secukinumab-induced pompholyx in a psoriasis patient.
Eichhoff G.
Dermatol Online J. 2020 Apr 15;26(4):13030/qt3669k149.
Cheiro-Pompholyx.
Hutchinson J.
Br Med J. 1878 Jan 12;1(889):54. doi: 10.1136/bmj.1.889.54.
